Global Immunocytokines Market: Snapshot
Immunocytokines are defined as the
molecules that are created when tumor-reactive monoclonal antibodies
link with cytokines to trigger immune cells. These molecules are
extensively being used for treating tumors as they have the ability to
activate immune cells with specific receptors. The global
immunocytokines market can be segmented on the basis of targeting sites,
disease condition, and clinical trials. Currently, immunocytokines are
being used for treating diseases such as tumors, cancer, and rheumatoid
arthritis. These molecules are usually targeting at the liver,
hypothalamus, fat muscle, B and T lymphocytes, and bone marrow
endothelium for treating the disease.
The research report on the
immunocytokines market by Transparency Market Research has been written
with utmost deliberation. The publication offers a granular view of the
global immunocytokines market and presents a case study of the
competitors operating in it. With a SWOT analysis, segments of the
global market have been studied with absolute clarity. The analysis
helps in understanding the strengths, weaknesses, opportunities, and
threats impacting the segments and deciding their course of progress for
the next few years. Additionally, Porter’s five forces analysis
determines the intensity of the competition in the global market and the
threat from the new entrants to the existing players. The research
report has been compiled with a purpose to assist every reader to take
wise business decisions that could lead to profitable ventures.
Global Immunocytokines Market: Trends and Drivers
The sudden rise in the investments for
conducting clinical trials to develop new molecular entities for
treating cancer has given the global immunocytokines market tremendous
boost. This has resulted in the introduction of improved molecular
entities that have greater tolerability and safety. Currently, the
global immunocytokines market is focused on conducting clinical trials
for categories such as tumor necrosis factor, first generation
Interleukin-2, second generation Interleukin-2, Interleukin-10,
Interleukin-12, Interleukin-15, and Interferon.
The high prevalence of cancer has been a
key growth driver for the global market. The market is also being driven
by the increasing healthcare expenditure, access to medical help, and
changing lifestyles that often result in chronic disorders and diseases.
The rising pool of geriatrics is also expected to lend an impetus to
the global market in the coming years.
Global Immunocytokines Market: Regional Outlook
Geographically, the global
immunocytokines market is segmented into Asia Pacific, North America,
Europe, and Rest of the World. Presently, the growing awareness about
cancer and its treatments across North America has put the regional
market ahead of others. The increasing investments in clinical trials to
develop new therapeutics and drugs for treating cancer in North America
are expected to benefit the regional market. Europe too is expected to
be a significant regional market in the near future.
On the other hand, developing countries
such as China, Malaysia, India, and Japan are expected to lead the Asia
Pacific immunocytokines market in the coming years. The growing trend of
medical tourism, increasing grants and funds from governments to
improve healthcare infrastructure, and the presence of several
pharmaceutical companies in the region are expected fuel growth of Asia
Pacific immunocytokines market.
Key Players Mentioned the Report are:
The important players operating in the
global immunocytokines market are Altor Biosciences Corporation,
Alkermes Plc, AstraZeneca Plc, Apeiron Biologics AG, CytImmune, Cytune
Pharma, ImmunGene, Inc., Immunomedics, Inc., MolMed S.p.A., Merck KGaA,
Nektar Therapeutics, Paladin Labs, Pfizer, Inc., F. Hoffmann-La Roche,
Ltd., Teva Pharmaceutical Industries Ltd., Valor Biotherapeutics, and
Targa Therapeutics Corporation.
No comments:
Post a Comment